Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase-ii study testing weekly platinum derivative combination chemotherapy as 2nd-line treatment in patients with advanced small-cell lung-cancer.
Sculier J, Thiriaux J, Bureau G, Lafitte J, Recloux P, Brohee D, Berchier M, Sergysels R, Mommen P, Paesmans M, Klastersky J, Lecomte J, Vanschaardenburg C, Richard V, Diana D, Fortin F, Tagnon A, Kustner U. Sculier J, et al. Among authors: richard v. Int J Oncol. 1995 Feb;6(2):425-9. doi: 10.3892/ijo.6.2.425. Int J Oncol. 1995. PMID: 21556555
[Lambert-Eaton syndrome. Apropos of 2 cases].
Gilbert P, Lefebvre P, Richard V, Henriet M, Leconte J, Thiriaux J. Gilbert P, et al. Among authors: richard v. Rev Pneumol Clin. 1992;48(6):275-8. Rev Pneumol Clin. 1992. PMID: 1339000 Review. French.
Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G. Gombos A, et al. Among authors: richard v. NPJ Breast Cancer. 2022 Mar 16;8(1):38. doi: 10.1038/s41523-022-00409-x. NPJ Breast Cancer. 2022. PMID: 35296682 Free PMC article. No abstract available.
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC).
Giuliani R, Durbecq V, Di Leo A, Paesmans M, Larsimont D, Leroy JY, Borms M, Vindevoghel A, Jerusalem G, D'Hondt V, Dirix L, Canon JL, Richard V, Cocquyt V, Majois F, Reginster M, Demol J, Kains JP, Delree P, Keppens C, Sotiriou C, Piccart MJ, Cardoso F. Giuliani R, et al. Among authors: richard v. Eur J Cancer. 2007 Mar;43(4):725-35. doi: 10.1016/j.ejca.2006.11.019. Epub 2007 Jan 23. Eur J Cancer. 2007. PMID: 17251007
Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.
Metzger-Filho O, Catteau A, Michiels S, Buyse M, Ignatiadis M, Saini KS, de Azambuja E, Fasolo V, Naji S, Canon JL, Delrée P, Coibion M, Cusumano P, Jossa V, Kains JP, Larsimont D, Richard V, Faverly D, Cornez N, Vuylsteke P, Vanderschueren B, Peyro-Saint-Paul H, Piccart M, Sotiriou C. Metzger-Filho O, et al. Among authors: richard v. PLoS One. 2013 Aug 19;8(8):e66848. doi: 10.1371/journal.pone.0066848. eCollection 2013. PLoS One. 2013. PMID: 23990869 Free PMC article. Clinical Trial.
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
Gombos A, Venet D, Ameye L, Vuylsteke P, Neven P, Richard V, Duhoux FP, Laes JF, Rothe F, Sotiriou C, Paesmans M, Awada A, Guiot T, Flamen P, Piccart-Gebhart M, Ignatiadis M, Gebhart G. Gombos A, et al. Among authors: richard v. NPJ Breast Cancer. 2021 Sep 21;7(1):125. doi: 10.1038/s41523-021-00331-8. NPJ Breast Cancer. 2021. PMID: 34548493 Free PMC article.
561 results